cigna glp-1 2025 drops employee coverage of obesity drugs cigna glp-1 coverage news Perspectives

USVs are graphed as box-whisker plots (control mice, n = 7

This lasting change is what makes laser lipo such a worthwhile investment for those struggling with stubborn thigh fat

Instead, we are happy to cheer our patients on as they achieve a more healthy weight and maintain it after they have finished their course of medication

Practical management strategies should include: Gradual titration to minimise gastrointestinal side effects, starting with the lowest available dose and increasing according to tolerance and glycaemic response Regular monitoring of HbA1c (individualised targets typically within 4858 mmol/mol or 6.57.5% in stable transplant patients, agreed with transplant and diabetes teams), body weight, and renal function Coordination with transplant teams to ensure immunosuppressant levels remain therapeutic, with additional trough level monitoring during GLP-1 initiation and after episodes of significant vomiting or diarrhoea Patient education regarding injection technique, storage requirements, and recognition of adverse effects requiring medical attention Dietary counselling to optimise nutritional intake whilst managing appetite suppression, ensuring adequate protein and micronutrient consumption for graft health Sick-day rules : temporarily withhold GLP-1 agonist during significant vomiting or diarrhoea, maintain hydration, and seek medical advice promptly Regular retinopathy screening for patients with diabetes, particularly when initiating semaglutide Patients should be advised to contact their GP or transplant team if they experience persistent vomiting, severe abdominal pain, signs of dehydration, or any symptoms suggesting infection or rejection, as these may require urgent assessment and temporary medication adjustment